Drugs / BNT162b6
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05472038 | Jul 2022 → Mar 2024 | COVID-19 | BioNTech SE | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNT162b6 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05472038 ↗ |